Atrium Therapeutics, Inc.
RNA
$13.19
$0.413.21%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/27/2026
-
Tickeron - Stocks
6/23/2026
-
PR Newswire
6/18/2026
-
The Cerbat Gem
6/18/2026
-
TipRanks: TheFly
6/18/2026
-
TipRanks: TheFly
6/17/2026
-
Tickeron - Stocks
6/16/2026
-
Simply Wall St
6/12/2026
-
Tickeron - Stocks
6/10/2026
-
Tickeron - Stocks
6/9/2026
-
Tickeron - Stocks
6/6/2026
-
Tickeron - Stocks
6/3/2026
-
The Cerbat Gem
5/29/2026
-
Tickeron - Stocks
5/27/2026
-
Tickeron - Stocks
5/23/2026
-
Tickeron - Stocks
5/21/2026
-
Tickeron - Stocks
5/19/2026
-
The Cerbat Gem
5/16/2026
-
Tickeron - Stocks
5/16/2026
-
The Cerbat Gem
5/15/2026
-
SeekingAlpha.com: All News
5/15/2026
-
The Cerbat Gem
5/14/2026
-
PR Newswire
5/12/2026
-
The Cerbat Gem
5/2/2026
-
The Cerbat Gem
4/30/2026
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, May 14, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Feb 15 and 19 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
619 876 0700
Address
10578 Science Center Drive
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The...
more